Their flagship product, the fNIR BrainSpy 28, is a portable neuroimaging device that uses hemodynamic responses to measure metabolic activity in specific brain areas. Newmanbrain's mission is to provide unbiased cognitive assessment for mass screening, offering an optimized fNIRs technology paired with AI-powered software that generates comprehensive reports on a patient's brain performance related to neurological conditions. They prioritize patient-oriented needs by offering multiple contact options such as phone, email, and an application form.